Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
KPCB XV Associates, LLC (CIK 1547838) reported $35.8M across 3 reported positions in its SEC 13F filing for 2022-09-30. Largest positions: RAPT ($15.6M, 43.54%), TWLO ($13.1M, 36.66%), ATRA ($7.1M, 19.79%), AUGX ($0, 0.00%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | RAPT | Rapt Therapeutics, Inc. | $15.6M | 43.54% | 648,531 | Trimmed |
| 2 | TWLO | Twilio Inc. | $13.1M | 36.66% | 190,047 | Hold |
| 3 | ATRA | Atara Biotherapeutics, Inc. | $7.1M | 19.79% | 1.9M | Hold |
| 4 | AUGX | Augmedix, Inc. | $0 | 0.00% | 0 | Exited |
Source: SEC Form 13F filings · as of 2022-09-30